Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Outer Layers of the Cell Envelope01:18

Outer Layers of the Cell Envelope

The outermost layers of prokaryotic cells play a critical role in their survival, virulence, and interaction with the environment. These layers, often composed of polysaccharides, polypeptides, or proteins, form protective and adhesive structures that vary in organization and function.Capsules and Slime LayersCapsules are highly organized, tightly bound layers that firmly attach to the bacterial cell wall. Capsules are usually made of polysaccharides, though some are made of polypeptides. These...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
COP Coated Vesicles00:59

COP Coated Vesicles

Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of different...
Clathrin Coated Vesicles01:12

Clathrin Coated Vesicles

Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
Prokaryotic Cells01:28

Prokaryotic Cells

Prokaryotes are small unicellular organisms that include the domains — Archaea and Bacteria. Bacteria include many common microorganisms, such as Salmonella and E. coli, while the Archaea include extremophiles that live in harsh environments, such as volcanic springs.
Like eukaryotic cells, all prokaryotic cells are surrounded by a plasma membrane, have genetic material in the form of single, circular DNA, a cytoplasm that fills the interior of the cell, and ribosomes that synthesize proteins.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of Liner Dissociation and All-Cause Revision With Uncemented Acetabular Components in Primary Total Hip Arthroplasty.

The Journal of arthroplasty·2025
Same author

Synthetic Lubrication of Bone Interfaces for Late-Stage Osteoarthritis Treatment.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

A Quantitative Model of Chemotherapeutic Drug Sensitivity as a Function of P-Glycoprotein Expression.

Molecules (Basel, Switzerland)·2025
Same author

Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations <i>in vitro</i> and <i>in vivo</i>.

bioRxiv : the preprint server for biology·2024
Same author

Intranasal Vaccination with Recombinant TLR2-Active Outer Membrane Vesicles Containing Sequential M2e Epitopes Protects against Lethal Influenza a Challenge.

Vaccines·2024
Same author

Flavonoid gossypetin protects alveolar bone and limits inflammation in ligature-induced periodontitis in mice.

Journal of periodontology·2024

Related Experiment Video

Updated: Jul 4, 2026

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
10:21

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

Published on: November 16, 2016

Engineered bacterial outer membrane vesicles with enhanced functionality.

Jae-Young Kim1, Anne M Doody, David J Chen

  • 1School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA.

Journal of Molecular Biology
|May 31, 2008
PubMed
Summary
This summary is machine-generated.

Researchers engineered bacterial outer membrane vesicles (OMVs) by fusing proteins to ClyA. This creates functional synthetic OMVs for diverse applications, including drug delivery and diagnostics.

More Related Videos

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
09:56

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Published on: October 13, 2021

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Related Experiment Videos

Last Updated: Jul 4, 2026

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
10:21

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

Published on: November 16, 2016

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
09:56

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Published on: October 13, 2021

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Area of Science:

  • Microbiology
  • Biotechnology
  • Protein Engineering

Background:

  • Bacterial outer membrane vesicles (OMVs) are promising nanocarriers.
  • Engineering OMVs with specific functionalities is crucial for advanced applications.
  • The toxin ClyA from Escherichia coli is a potential platform for OMV modification.

Purpose of the Study:

  • To engineer bacterial OMVs with enhanced functionality using ClyA fusions.
  • To demonstrate the co-localization and retained activity of heterologous proteins within OMVs.
  • To explore the potential of engineered OMVs in diagnostics, therapeutics, and mechanistic studies.

Main Methods:

  • Fusion of heterologous proteins (enzymes, antibody fragments, fluorescent proteins) to ClyA.
  • Expression and localization of ClyA fusion proteins in bacterial OMVs.
  • Functional assays to confirm the activity of fused proteins (hydrolysis, antigen binding, fluorescence).
  • Tracking of fluorescent OMVs interacting with human epithelial cells.

Main Results:

  • Chimeric ClyA fusion proteins were successfully localized in bacterial OMVs.
  • Fused proteins retained their biological activity, enabling specific functions.
  • Engineered OMVs demonstrated enzymatic activity (beta-lactamase, organophosphorus hydrolase).
  • Synthetic immuno-OMVs specifically bound to their target antigen.
  • Fluorescent OMVs allowed for tracking during cellular interactions.

Conclusions:

  • ClyA serves as a versatile fusion partner for creating functionalized OMVs.
  • Engineered OMVs offer a platform for diverse biotechnological applications.
  • This approach facilitates mechanistic studies of OMV secretion and host cell interactions.
  • Designer OMVs hold potential for targeted drug delivery and diagnostics.